Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.

Pallotta RH, Wangchinda W, Sallerson SR, Eschenauer GE, Marshall VD, Pierce VM, Pogue JM, Aitken SL.

Open source

DOI
10.1093/cid/ciag535
Published
2026-09-02
Container
Clin Infect Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag535,
  title = {Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.},
  author = {Pallotta RH and  Wangchinda W and  Sallerson SR and  Eschenauer GE and  Marshall VD and  Pierce VM and  Pogue JM and  Aitken SL.},
  year = {2026},
  journal = {Clin Infect Dis},
  doi = {10.1093/cid/ciag535},
  url = {https://doi.org/10.1093/cid/ciag535}
}

RIS

TY  - JOUR
TI  - Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.
AU  - Pallotta RH
AU  -  Wangchinda W
AU  -  Sallerson SR
AU  -  Eschenauer GE
AU  -  Marshall VD
AU  -  Pierce VM
AU  -  Pogue JM
AU  -  Aitken SL.
PY  - 2026
JO  - Clin Infect Dis
DO  - 10.1093/cid/ciag535
UR  - https://doi.org/10.1093/cid/ciag535
ER  - 

APA

RH, P., W, W., SR, S., GE, E., VD, M., VM, P., JM, P., & SL., A. (2026). Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.. Clin Infect Dis. https://doi.org/10.1093/cid/ciag535

Source records